期刊文献+

液压转基因技术用于脂肪肝大鼠的肝脏转基因实验

Application of hydrodynamics-based transgene to gene transfection in rat fatty liver
下载PDF
导出
摘要 目的探讨液压转基因技术(HDT)应用于大鼠脂肪肝转基因的条件、方法。方法以不同速度将不同体积、浓度的绿色荧光蛋白基因质粒pEGFP-C1一次性注射到脂肪肝大鼠尾静脉,于注射后不同时间取大鼠(各4只)各肝叶制备冷冻切片,在波长488nm的荧光显微镜下观察、计数各肝叶绿色荧光蛋白阳性细胞。结果在pEGFP-C1浓度为33mg/L、注射速度为2ml/s、注射液体积为大鼠体重的8.5%条件下,注射质粒后6h,各肝叶绿色荧光蛋白阳性细胞比例最高,其中,蒂状叶的绿色荧光蛋白阳性细胞约占18%,左叶约占14%、中叶约占12.5%、右叶约占10%,尾状叶约占8%。转基因后24h绿色荧光蛋白的表达量逐渐减少,至72h时各肝叶均难以检出绿色荧光蛋白阳性细胞。结论大鼠尾静脉液压转基因技术可用于脂肪肝大鼠的肝脏转基因研究,转基因的适宜条件为:质粒溶液浓度33mg/L,注射量占大鼠体重的8.5%,注射速度为2ml/s,观察转基因效果的适宜时间是转基因后6~24h。 Objective To study the condition and method of hydrodynamics-based transgene(HDT) in rat fatty liver. Methods Inject different dosages and concentrations of green fluorescent protein plasmid pEGFP-C1 at different speeds, then collect 4 rats' liver leaves at different time points after injection and prepare their frozen section, finally observe and quantify the GFP expression with fluorescence microscope at 488 nm excitation wavelength. Results Plasmid pEGFP-C1 concentration 33mg/L, injection speed 2ml/s, injection volume 8.5% of rat body weight, injected plasmid. After 6 hours of injection, GFP-positive cells rate of pedicel leaf is about 18% , left leaf about 14% , middle leaf about 12.5% , right leaf about 10% and tail leaf about 8%. GFP begin to gradually reduce since 24 hours, until 72 hours almost no GFP-positive ceils were checked in all liver leaves. Conclusion Hydrodynamics-based transgene can be applied to rat fatty liver, the appropriate conditions of this method are 33mg/L plasmid concentration, 8.5% rat avoirdupois, 2ml/s injection speed, and the suitable time to observe the proportion of GFP-positive cells is 6-24 hours after gene injection.
出处 《解剖学报》 CAS CSCD 北大核心 2010年第1期160-164,共5页 Acta Anatomica Sinica
基金 河南省重大公益性科研计划项目资助(081100910700)
关键词 绿色荧光蛋白 脂肪肝 液压转基因技术 大鼠 Green fluorescent protein Fatty liver Hydrodynamics-based transgene Rat
  • 相关文献

参考文献16

  • 1Brunt EM.Nonalcoholic steatohepatitis:definition and pathology[J].Semin Liver Dis,2001,21(1):3-16.
  • 2Powell EE,Jonsson JR,Clouston AD.Steatosis:co-factor in other liver diseases[J].Hepatology,2005,42(1):5-13.
  • 3Brunt EM.Nonalcoholic steatohepatitis[J].Semin Liver Dis,2004,24(1):3-20.
  • 4Wolff JA,Malone RW,Williams P,et al.Direct gene transfer into mouse muscle in vivo[J].Science,1990,247(4949 pt 1):1465-1468.
  • 5Liu F,Song Y,Liu D.Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA[J].Gene Ther,1999,6(7):1258-1266.
  • 6Zhang G,Budker V,Wolff JA.High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA[J].Hum Gene Ther,1999,10(10):1735-1737.
  • 7徐存拴,邢雪琨,谢来峰,张明,方方,崔胜男,王磊,张富春.液压转基因技术应用于大鼠肝脏转基因实验[J].解剖学报,2009,40(1):103-107. 被引量:6
  • 8谢来峰,张延斌,郭学强,徐存拴.大鼠脂肪肝成模过程中肝组织结构变化[J].陕西医学杂志,2009,38(11):1448-1451. 被引量:2
  • 9贺晨霞,冯登敏,陈立,陈浩明,姚纪花,沈琦,卢大儒,薛京伦,吴文君,丁友法.尾静脉大容量快速注射法介导的人凝血因子Ⅸ基因在小鼠肝内的高效表达[J].科学通报,2003,48(5):447-451. 被引量:5
  • 10Chen ZY,Yant SR,Lie CY,et al.Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver[J].Mol Ther,2001,3(3):403-410.

二级参考文献14

  • 1王琪,卢大儒,邢永娜,施前,王宏伟,薛京伦,邱信芳.重组腺病毒介导的基因转移系统的建立以及在离体及活体中表达[J].复旦学报(自然科学版),1996,35(6):601-606. 被引量:3
  • 2Zhang G, Song YK, Liu D. Long-term expression of human alphalantitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure [ J]. Gene Ther, 2000, 7 (15) :1344-1349.
  • 3Miao CH, Thompson AR, Loeb K, et al. Long-term and therapeuticlevel hepatic gene expression of human factor FIX after naked plasmid transfer[J]. Mol Ther, 2001, 3 (6):947-957.
  • 4Chen ZY, Yant SR, lie CY, et al. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver[J]. Mol Ther, 2001, 3 (3):403-410.
  • 5Ge Y, Powell S, Van Roey M, et al. Factors influencing the development of an anti-factor IX ( F IX ) immune response following administration of adeno-associated virus-F IX [ J ]. Blood, 2001, 97 (12) :3733-3737.
  • 6Waterhouse PM, Wang MB, Lough T. Gene silencing as an adaptive defence against virus[J]. Nature, 2001, 411 (6839):834-841.
  • 7Qin L, Ding Y, Pahud DR, et al. Promoter attenuation in gene therapy: interferon-u and tumor necrosis factor-α inhibit transgene expression [J]. Hum Gene Ther, 1997, 8 (17) : 2019-2029.
  • 8Harms JS, Splitter GA. Interferon-7 inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian HNCI promoter[J]. Hum Gene Ther, 1995, 6 (10): 1291-1297.
  • 9Clark A J, Harold G, Yull F. Mammalian cDNA and prokaryotie reporter sequences silence adjacent transgenes in transgenic mice[ J]. Nucleic Acids Res, 1997, 25 (5) : 1009-1014.
  • 10Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo [ J]. Science, 1990, 247 (4949 Pt 1 ) : 1465-1468.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部